Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Alsayed, Yazan
17  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis..:

Heuck, Christoph J ; Szymonifka, Jackie ; Hansen, Emily...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677537.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
2

Extramedullary disease portends poor prognosis in multiple ..:

Usmani, Saad Z ; Heuck, Christoph ; Mitchell, Alan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487453.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
3

Primary plasma cell leukemia: clinical and laboratory prese..:

Usmani, Saad Z ; Nair, Bijay ; Qu, Pingping...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426639.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
4

Pharmacogenomics of bortezomib test-dosing identifies hyper..:

Shaughnessy, John D ; Qu, Pingping ; Usmani, Saad...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186329.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
5

Total Therapy 3 for multiple myeloma: prognostic implicatio..:

van Rhee, Frits ; Szymonifka, Jackie ; Anaissie, Elias...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938233.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
6

Superior results of Total Therapy 3 (2003-33) in gene expre..:

Nair, Bijay ; van Rhee, Frits ; Shaughnessy, John D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879104.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
7

High-risk myeloma is associated with global elevation of mi..:

Zhou, Yiming ; Chen, Lijuan ; Barlogie, Bart...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867889.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
8

International Staging System and Metaphase Cytogenetic Abno..:

Waheed, Sarah ; Shaughnessy, John D ; van Rhee, Frits...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023833.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
9

TP53 Deletion is Not an Adverse Feature in Multiple Myeloma..:

Shaughnessy, John D ; Zhou, Yiming ; Haessler, Jeff...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675654.  , 2009
Link: http://www.ncbi.nlm.nih...
 
?
10

Complete remission in multiple myeloma examined as time-dep..:

Hoering, Antje ; Crowley, John ; Shaughnessy, John D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727409.  , 2009
Link: http://www.ncbi.nlm.nih...
 
?
11

Gene expression profiling of plasma cells at myeloma relaps..:

Nair, Bijay ; Shaughnessy, John D ; Zhou, Yiming...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710916.  , 2009
Link: http://www.ncbi.nlm.nih...
 
?
12

Seven-year median time to progression with thalidomide for ..:

Barlogie, Bart ; van Rhee, Frits ; Shaughnessy, John D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569167.  , 2008
Link: http://www.ncbi.nlm.nih...
 
?
13

Thalidomide arm of Total Therapy 2 improves complete remiss..:

Barlogie, Bart ; Pineda-Roman, Mauricio ; van Rhee, Frits...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569166.  , 2008
Link: http://www.ncbi.nlm.nih...
 
?
14

Cytogenetically defined myelodysplasia after melphalan-base..:

Barlogie, Bart ; Tricot, Guido ; Haessler, Jeff...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200826.  , 2008
Link: http://www.ncbi.nlm.nih...
 
?
15

High serum-free light chain levels and their rapid reductio..:

van Rhee, Frits ; Bolejack, Vanessa ; Hollmig, Klaus...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924775.  , 2007
Link: http://www.ncbi.nlm.nih...
 
1-15